Overview

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Status:
Recruiting

Trial end date:
2021-11-01

Target enrollment:

Participant gender:

Summary

This is an open-label, non randomised, single-dose, study in male and female subjects with renal impairment (severe and if required mild & moderate) compared to male and female subjects with normal renal function.

Phase:

Phase 1

Details

Lead Sponsor:

Mitsubishi Tanabe Pharma Development America, Inc.